New Targeted Strategies for ESR1-Mutated Breast Cancer

	Breast Cancer
	The latest breast cancer news from News Medical

A new chapter in breast cancer treatment has begun with the FDA approval of vepdegestrant for ER+/HER2- ESR1-mutated advanced breast cancer. Learn how targeted protein degradation and PROTAC research are opening new therapeutic possibilities and driving innovation in precision oncology and hormone receptor-targeted therapies.

Read the article

			Study Connects Lysosomal Lipid Movement Directly to Cellular Growth Signaling While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for the metabolite. Some tumor cells use as much cholesterol as they can access to accelerate their growth beyond the capabilities of normal cells.

			Explainable AI could make breast cancer drug predictions safer and clearer AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast cancer treatment. The review proposes an interpretability-driven framework that links multi-omics data, mechanistic validation, and clinical translation to make AI predictions more transparent and clinically useful.

	Light-driven nanomotors improve multimodal breast cancer treatment efficacy The nanomotor starts with bowl‑shaped mesoporous polydopamine (PDA) nanoparticles. These biocompatible bowls are loaded with two key payloads: Fe(II) ions as a Fenton catalyst, and BNN6, a thermally sensitive NO donor.

	Research offers clearer genetic blueprint of breast cancer variants A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore), has identified eight new "signatures" of DNA patterns (gains and/or losses) in breast cancer.

	Vitamin D deficiency linked to higher postoperative breast cancer pain Vitamin D deficiency is associated with more moderate to severe pain following breast cancer surgery and an increased consumption of opioid drugs, finds research published online in the journal Regional Anesthesia & Pain Medicine.

	Common allergy medication may also help fight aggressive cancers A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine study that uncovered how tumors hijack common white blood cells to evade immunotherapy.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026